Literature DB >> 19224889

Ataxia-telangiectasia patients presenting with hyper-IgM syndrome.

J G Noordzij1, N M Wulffraat, A Haraldsson, I Meyts, L J van't Veer, F B L Hogervorst, A Warris, C M R Weemaes.   

Abstract

Ataxia-telangiectasia (A-T) is characterised by progressive neurological abnormalities, oculocutaneous telangiectasias and immunodeficiency (decreased serum IgG subclass and/or IgA levels and lymphopenia). However, 10% of A-T patients present with decreased serum IgG and IgA with normal or raised IgM levels. As cerebellar ataxia and oculocutaneous telangiectasias are not present at very young age, these patients are often erroneously diagnosed as hyper IgM syndrome (HIGM). Eight patients with A-T, showing serum Ig levels suggestive of HIGM on first presentation, are described. All had decreased numbers of T lymphocytes, unusual in HIGM. The diagnosis A-T was confirmed by raised alpha-fetoprotein levels in all patients. To prevent mistaking A-T patients for HIGM it is proposed to add DNA repair disorders as a possible cause of HIGM.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19224889     DOI: 10.1136/adc.2008.149351

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  26 in total

1.  Ataxia Telangiectasia Masquerading as Hyper IgM Syndrome.

Authors:  Amit Rawat; Kohsuke Imai; Deepti Suri; Anju Gupta; Swapnil Bhisikar; Biman Saikia; Ranjana W Minz; Shobha Sehgal; Surjit Singh
Journal:  Indian J Pediatr       Date:  2015-07-30       Impact factor: 1.967

Review 2.  Update on the hyper immunoglobulin M syndromes.

Authors:  E Graham Davies; Adrian J Thrasher
Journal:  Br J Haematol       Date:  2010-02-23       Impact factor: 6.998

Review 3.  Prospects for modulating the CD40/CD40L pathway in the therapy of the hyper-IgM syndrome.

Authors:  Xiangxue Meng; Bin Yang; Wen-Chen Suen
Journal:  Innate Immun       Date:  2017-11-13       Impact factor: 2.680

4.  Respiratory Complications in Patients with Hyper IgM Syndrome.

Authors:  Bobak Moazzami; Reza Yazdani; Gholamreza Azizi; Fatemeh Kiaei; Mitra Tafakori; Mohammadreza Modaresi; Rohola Shirzadi; Seyed Alireza Mahdaviani; Mahsa Sohani; Hassan Abolhassani; Asghar Aghamohammadi
Journal:  J Clin Immunol       Date:  2019-06-11       Impact factor: 8.317

5.  A novel ATM mutation associated with elevated atypical lymphocyte populations, hyper-IgM, and cutaneous granulomas.

Authors:  Heather Minto; Kofi A Mensah; Paul R Reynolds; Eric Meffre; Kira Rubtsova; Erwin W Gelfand
Journal:  Clin Immunol       Date:  2019-01-09       Impact factor: 3.969

Review 6.  The hyper IgM syndromes.

Authors:  Nashmia Qamar; Ramsay L Fuleihan
Journal:  Clin Rev Allergy Immunol       Date:  2014-04       Impact factor: 8.667

7.  Utility of DNA, RNA, Protein, and Functional Approaches to Solve Cryptic Immunodeficiencies.

Authors:  Margot A Cousin; Matthew J Smith; Ashley N Sigafoos; Jay J Jin; Marine I Murphree; Nicole J Boczek; Patrick R Blackburn; Gavin R Oliver; Ross A Aleff; Karl J Clark; Eric D Wieben; Avni Y Joshi; Pavel N Pichurin; Roshini S Abraham; Eric W Klee
Journal:  J Clin Immunol       Date:  2018-04-18       Impact factor: 8.317

8.  Ataxia telangiectasia in Turkey: multisystem involvement of 91 patients.

Authors:  Hacer Akturk; Murat Sutcu; Ayper Somer; Sanem Piskin; Manolya Acar; Meral Ozmen; Umut Altinoglu; Burak Tatli; Nuran Salman
Journal:  World J Pediatr       Date:  2017-01-25       Impact factor: 2.764

9.  Rubella Virus-Associated Cutaneous Granulomatous Disease: a Unique Complication in Immune-Deficient Patients, Not Limited to DNA Repair Disorders.

Authors:  David Buchbinder; Fabian Hauck; Michael H Albert; Anita Rack; Shahrzad Bakhtiar; Anna Shcherbina; Elena Deripapa; Kathleen E Sullivan; Ludmila Perelygina; Marc Eloit; Bénédicte Neven; Philippe Pérot; Despina Moshous; Félipe Suarez; Christine Bodemer; Francisco A Bonilla; Louise E Vaz; Alfons L Krol; Christoph Klein; Mikko Seppanen; Diane J Nugent; Jasjit Singh; Hans D Ochs
Journal:  J Clin Immunol       Date:  2019-01-03       Impact factor: 8.317

10.  Ataxia telangiectasia associated with nodular regenerative hyperplasia.

Authors:  Ki L Milligan; Karen Schirm; Stephanie Leonard; Ashleigh A Hussey; Anahita Agharahimi; David E Kleiner; Ivan Fuss; Shilpa Lingala; Theo Heller; Sergio D Rosenzweig
Journal:  J Clin Immunol       Date:  2016-09-26       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.